CClinicalTrials.gg
CompletedNCT04147429Updated Jul 27, 2020

Newborn Nursery Reach Out and Read

An interventional study of Early Literacy Intervention in Literacy, sponsored by Duke University. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2020-07-27.

Sponsored by Duke University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Sex
All
01

Study summary

The purpose of this research study is to learn new things about how parents and others who care for babies think about sharing books with their baby and how they might respond to guidance from their doctors. The study involves participants filling out a survey with questions about a newborn baby and thoughts about the baby's development. The study should not take more than an hour and fifteen minutes during the delivery hospital stay and another 20 minutes at the baby's one month well child visit by phone or emailed survey link. Participants may also be interviewed and asked some questions about these topics. The conversation will be audio recorded, and should last no more than 30 minutes. The survey should take no more than 15 minutes to complete. The participant and their child will be randomized, like flipping a coin, to either receive the study intervention book, Cluck and Moo, along with standard or care or solely standard of care at your time of hospital discharge. The greatest risks to this study would be feeling uncomfortable about answering some of the questions and potential risk of loss of confidentiality.

02

Conditions studied

  • Literacy
03

In context

Lead sponsor

Duke University is the lead sponsor of 2,025 studies on the registry; 275 are open to participants now.

Of its 194 completed or terminated interventional studies of FDA-regulated products, 159 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Child delivered at Duke Hospital Birthing Center
  • Families who can read and write in English
  • Families with children born at >36 weeks gestation
  • Families who plan to continue primary pediatric care with Duke Children's Primary Care

Exclusion criteria

Exclusion Criteria:

  • Parent with severe medical or mental health condition limiting ability to attend appointments
  • Newborn with severe medical condition
  • Families who plan to move out of state in the next 6 months
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • No intervention
    Usual care

    Newborns randomized to the usual care group will receive standard education about safe sleep practices, measuring temperatures and newborn feeding needs. This information will be accompanied by printed instructions that will be added to the family's discharge instructions. This reflects current practice in the Duke Hospital Newborn Nursery.

  • Experimental
    Intervention

    In addition to usual care, families randomized to the intervention group will receive an early literacy intervention, delivered by a trained research assistant. To ensure intervention and delivery fidelity, the PI will meet with research assistants at bi-weekly intervals to review procedures and perform structured observations of intervention delivery.

    Behavioral: Early Literacy Intervention

Interventions

  • BehavioralEarly Literacy Intervention

    Similar to the standard Reach out and Read model, parents will be given a high-contrast board book, Cluck and Moo, and education about the importance of and how to engage with newborns in early shared reading behaviors. This will include instructive information for families about using books to stimulate newborns through pictures and spoken words.

06

What researchers measure

Primary outcomes

  1. Program acceptability as measured by survey data

    Survey data will be analyzed using grounded theory.

    Time frame: 1 month

  2. Program acceptability as measured by structured interviews

    The structured interviews will be evaluated and themes and subthemes will be identified using NVivo software.

    Time frame: 1 month

  3. Program feasibility assessed by determining the cost of books required for the intervention

    Time frame: 1 month

  4. Program feasibility assessed by the time required to complete enrollment

    Time frame: 1 month

  5. Program feasibility assessed by the time required to complete the intervention

    Time frame: 1 month

  6. Program feasibility assessed by the number of eligible families enrolled in the study.

    Time frame: 1 month

  7. Program feasibility assessed by the percentage of families who are followed through to study completion

    Time frame: 1 month

Secondary outcomes

  1. Family's home literacy environment as measured by the READ subscale of the StimQ2-Infant.

    Age appropriate items will be pulled from the StimQ2-Infant READ subscale. The StimQ2-Infant READ subscale measures a family's shared reading behaviors in the home.

    Time frame: 1 month

07

Study locations

1 site
  • Duke University Medical Center
    Durham, North Carolina 27705, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 27, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04147429
Lead sponsor
Duke University
Responsible party
Sponsor
First posted
Nov 1, 2019
Start date
Oct 30, 2019
Primary completion
Apr 18, 2020
Completion
Apr 18, 2020
Last update
Jul 27, 2020

Study contacts

Elizabeth Erickson, MD
principal investigator · Duke University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion